Infectious diseases remain one of the greatest global health challenges. France plays a key role in combating infectious diseases through innovation, rapid response, and international cooperation.
French Innovation in Infectious Diseases
French companies stand out for their major breakthroughs. Osivax, for instance, is developing a universal flu vaccine (OVX836) capable of protecting against multiple viral strains. Supported by international funding, this project illustrates the global reach of French biotech.
“Our ambition is clear: to anticipate pandemics and provide global protection.”
— Alexandre Le Vert, CEO of Osivax
Strengthening Health Sovereignty and Global Supply Chains
Through the France 2030 plan, the country is investing heavily in bioproduction and biopharmaceuticals, aiming to produce 60 biomedicines by 2030.
These investments are designed not only to ensure national sovereignty but also to secure global supply chains and guarantee equitable access to treatments.
A Holistic Approach: Human and Environmental Health
Fighting infectious diseases goes beyond vaccines. It also means reducing environmental factors that weaken health.
Air pollution, for example, worsens respiratory diseases and increases vulnerability to infections.
French public health agencies are working to reduce this exposure, demonstrating an integrated approach aligned with the One Health vision, which connects human, animal, and environmental health.
A Strong International Commitment
France does not stop at innovation; it acts globally. It is the second-largest contributor to the Global Fund against AIDS, tuberculosis, and malaria, and the leading contributor to Unitaid, while supporting Gavi for vaccination in low-income countries.
Business France plays a key role in this dynamic:
“Working with Business France gave us credibility and visibility internationally. Their support was decisive in accessing the right networks and preparing our entry into North America.”
— Paul Bravetti, CEO of Brenus Pharma
Conclusion
By combining scientific innovation, industrial capacity, and a global vision, France positions itself as a key player in the fight against infectious diseases. Its companies, research institutes, and public policies are helping build a safer future for all.
